This study aimed to evaluate the published data on the effect of cannabis use in perimenopausal and postmenopausal women to alleviate menopausal symptoms, insomnia and anxiety.Databases searched in... 目的:本研究旨在评估已发表的关于在女性围绝经期应用大麻缓解绝经期及绝经后绝经症状、失眠和焦虑作用的相关数据。方法:搜索的数据库包括 Ovid MEDLINE、PubMed、Ovid Embase、Web of Science、Scopus、CINAHL、PsycINFO、Cochrane、LILACS 和 AMED。纳入的研究评估围绝经期或绝经后女性, 应用大麻的影响和绝经症状。结果:共检索...
10 July 2023 in Journal of the Medical Library Association
Trusted patient education materials are the backbone of an effective consumer health library. However, members of the LGBTQ+ community may not see themselves or their families reflected in many resources due to the gendered and non-inclusive language they are written in. This article outlines some suggestions for concrete actions that patient librarians can take to ensure that their materials are not excluding LGBTQ+ patients.
Background: Numerous studies have aimed to predict prenatal and neonatal outcomes for pregnancies complicated by congenital cytomegalovirus (CMV). Presently, assessing CMV severity prenatally relies largely on fetal imaging. A controversy exists regarding CMV viral load (VL) and its association with fetal and neonatal sequelae. Objective: To perform a systematic review and meta-analysis investigating the association between CMV DNA VL in amniotic fluid and fetal and neonatal outcomes in pregnancies with congenital CMV. Results: All cohort, case-control and observational studies that compared outcomes of fetuses with congenital CMV and provided information on individual patient CMV VL quantified in copies per milliliter (c/mL) from inception to January 2023 were included, with no geographical or language restrictions. A total of 1251 citations were reviewed with eight studies meeting inclusion criteria and included in meta-analysis. Affected pregnancies had a higher VL in the amniotic fluid compared to those unaffected with a mean difference of 2.2e+7 (range 1.5e+7 to 2.8e+7). In subgroup analysis, the VL was significantly higher in the fetuses, with imaging findings related to CMV compared to asymptomatic fetuses with a mean difference of 4.1e+7 (95% CI 2.8e+7–5.4e+7). However, among babies with congenital CMV, the VL was not significantly different between symptomatic and asymptomatic babies. Conclusions: Amniotic fluid CMV VL is associated with fetal sequalae in congenital CMV, with a higher VL conferring a greater risk for prenatal injury.
Genitourinary syndrome of menopause (GSM) may arise from the hypoestrogenism caused by ovarian function destruction following gynecological cancer treatments. GSM may also be present in menopausal women and its symptoms might be exacerbated by cancer treatments. Historically, patients with hormone-dependent gynecological cancer and physicians have been less comfortable using vaginal estrogen due to fear of recurrence. CO2 vaginal laser therapies have demonstrated efficacy as a non-hormonal alternative for GSM treatment in healthy menopausal patients. The objective of this study was to evaluate the data on the effect of a CO2 vaginal laser for the management of GSM in gynecological cancer patients. Databases searched included MEDLINE, Embase, PubMed, Cochrane and Google Scholar. Selected studies assessed use of a CO2 vaginal laser in gynecological cancer patients with GSM. A total of 269 studies were retrieved. Four studies met the inclusion criteria. Each study followed a different type of CO2 vaginal laser protocol for the management of GSM in gynecological cancer patients. There are no randomized controlled trials that assess the use of a CO2 vaginal laser in gynecologic cancer patients. The number of published gynecological cancer patients treated with a CO2 laser for the management of GSM is extremely limited (N < 100). There is a lack of literature on the impact and safety of vaginal CO2 laser use to manage GSM in gynecologic cancer patients.
To systematically evaluate and compare the effectiveness of surgical and nonsurgical pitch elevation techniques in transgender women using acoustic outcomes and validated patient-reported outcome measures (PROMs). A systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Comprehensive searches of Ovid MEDLINE, Embase, CENTRAL, PsycINFO, CINAHL, and gray literature were completed through January 2025. Included studies involved transgender women (≥18 years) undergoing pitch elevation via surgical (Wendler glottoplasty [WG], cricothyroid approximation [CTA], vocal fold shortening and retrodisplacement of the anterior commissure [VFSRAC], and laser-assisted voice adjustment [LAVA]), laser-reduction glottoplasty [LRG], nonsurgical (voice therapy [VT]), or combination approaches. Eligible studies reported both changes in fundamental frequency (F0) and validated PROMs, such as the Voice Handicap Index (VHI) or Trans Woman Voice Questionnaire (TWVQ). Risk of bias was assessed using the Cochrane Risk of Bias Tool and Newcastle-Ottawa Scale. Data were synthesized narratively with weighted means calculated for key outcomes. Twenty-two studies (N = 977) were included. VFSRAC yielded the highest mean F0 increase (+73.3 Hz), followed by WG (+54.1 Hz), VT (+39.9 Hz), CTA (+30.3 Hz), and LAVA (+26 Hz). WG + VT showed comparable F0 gains (+54.5 Hz) with more consistent outcomes. TWVQ scores improved most with WG + VT (-47.9), followed by WG (-29.0) and VT (-18.7). VHI scores improved most with LAVA (-48.0) and WG (-21.7); VFSRAC and CTA showed modest PROM improvements. Adverse events, including granuloma and vocal fatigue, were more common with surgical combinations. Follow-up ranged from 2 weeks to 4.4 years, with most studies reporting 6-12 months. Surgical and nonsurgical interventions both elevate pitch and improve voice-related quality of life. Surgery provides greater F0 gains, while combining VT enhances patient satisfaction. Findings support individualized care and the need for standardized PROMs in future studies.